+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prognostic value of preoperative von Willebrand factor plasma levels in patients with Glioblastoma



Prognostic value of preoperative von Willebrand factor plasma levels in patients with Glioblastoma



Cancer Medicine 5(8): 1783-1790



Circulating biomarker for malignant gliomas could improve both differential diagnosis and clinical management of brain tumor patients. Among all gliomas, glioblastoma (GBM) is considered the most hypervascularized tumor with activation of multiple proangiogenic signaling pathways that enhance tumor growth. To investigate whether preoperative antigen plasma level of von Willebrand Factor (VWF:Ag) might be possible marker for GBM onset, progression, and prognosis, we retrospectively examined 57 patients with histological diagnosis for GBM and 23 meningiomas (MNGs), benign intracranial expansive lesions, enrolled as controls. Blood samples were collected from all the patients before tumor resection. Plasma von Willebrand Factor (VWF):Ag levels were determined by using a latex particle-enhanced immunoturbidimetric assay. The median levels of vWF:Ag were significantly higher in GBMs than in meningiomas (MNGs) (183 vs. 133 IU/dL, P = 0.01). The cumulative 1-year survival was significantly shorter in patients with VWF:Ag levels >200 IU/dL than in those with levels <200 IU/dL and increased VWF levels were associated with a threefold higher risk of death in GBM patients. Our data suggest that VWF:Ag could be a circulating biomarker of disease malignancy, that could be considered, in association with other genetic and epigenetic factors, currently available in the GBM management. Future studies should investigate whether plasma VWF:Ag levels could also be used to monitor therapeutic effects and whether it may have a prognostic value.

(PDF emailed within 0-6 h: $19.90)

Accession: 058637978

Download citation: RISBibTeXText

PMID: 27236861

DOI: 10.1002/cam4.747


Related references

Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma. Cancer 120(24): 3972-3980, 2015

Preoperative plasma levels of von Willebrand factor in patients with cervical carcinoma. Minerva Ginecologica 40(3): 159-162, 1988

Plasma levels of von Willebrand factor, von Willebrand factor propeptide and factor VIII in carriers and patients with nephrogenic diabetes insipidus. Thrombosis Research 125(6): 554-556, 2010

Prognostic value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen levels in patients with coronary artery disease. Thrombosis and Haemostasis 103(3): 623-629, 2010

Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure. European Journal of Clinical Investigation 33(11): 941-948, 2003

Comparison between plasma Von Willebrand factor and VWF antigen II levels in normal individuals and patients with Von Willebrand disease. British Journal of Haematology 93(SUPPL 2): 173, 1996

Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation. European Journal of Clinical Investigation 43(10): 1032-1038, 2014

Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a a real worlda community cohort of patients with atrial fibrillation. 2013

The prognostic role of preoperative serum albumin levels in glioblastoma patients. Bmc Cancer 15: 108, 2016

Plasma levels of soluble E-selectin are elevated while plasma levels of von Willebrand factor and plasminogen activator inhibitor-1 remain unaffected in patients with mild hypertension. European Heart Journal 18(ABSTR SUPPL ): 187, 1997

Prognostic value of plasma levels of thrombomodulin and von Willebrand factor in Egyptian children with acute lymphoblastic leukemia. Journal of Oncology Pharmacy Practice 20(5): 356-361, 2015

The anti-von Willebrand factor aptamer ARC1779 increases von Willebrand factor levels and platelet counts in patients with type 2B von Willebrand disease. Thrombosis and Haemostasis 108(2): 284-290, 2012

Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia. Thrombosis and Haemostasis 101(2): 305-311, 2009

The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels. Blood 121(26): 5228-5237, 2013

ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens. Thrombosis and Haemostasis 97(4): 534-541, 2007